Source Post

Manipal Health Enterprises IPO | Analysis | GMP | Review

The creator analyzes the upcoming IPO of Manipal Health Enterprises, which is opening from July 29-31 with a price band of 590 and a company valuation of 77,000 crore. The company is raising around 9000 crore, with 8000 crore going to the company for loan repayment and minority stake buyouts, and 1000 crore from promoters and initial shareholders selling their stakes. While the company's revenue has grown, its net profit has declined year-on-year due to increased finance costs from substantial borrowing and depreciation, despite operational performance being described as good.

Linked Mentions

Tickers discussed in this post

MBINeutralLow ConvictionResearch Only

Columbia Asia hospitals, acquired by Manipal, are noted for their high operating profit margins.

NODKNeutralLow ConvictionResearch Only

United India Insurance is recommended as a government-owned insurance company for health insurance.

SUGPNeutralLow ConvictionResearch Only

New India Insurance is mentioned as a government-owned insurance company to consider for health insurance.

NIPGNeutralLow ConvictionSignal-backedPrimary

Manipal Health Enterprises is launching its IPO from July 29-31 with a price band of 590 and a valuation of 77,000 crore, aiming to raise 9000 crore.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.